Faculty profile

Nicola Wright

ResearcherPediatricsUniversity of Calgary

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Calgary directory, so their courses and email address may be missing. Find their university profile.

Nicola Wright

Researcher

Pediatrics

Health Sciences

University of Calgary

Calgary, Alberta, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
6 publications in the last five years, latest in 2026.
Senior (last) author on 1 recent paper, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2022.
Supervisor on 1 trainee award (1 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Adenine Base Editing Gene Editing Gene Therapy Clinical Trial Inborn Errors Of Immunity Rare Diseases Severe Combined Immune Deficiency

Latest papers

Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.
Vaccine · 2026
Hospitalization Through Families' Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada.
Pediatric blood & cancer · 2026
Reducing antibiotic overuse in immunocompetent children with febrile neutropenia in a pediatric emergency department: a quality improvement initiative.
CJEM · 2026 · senior author

All 14 publications

Latest funding

Building the First Made-in-Canada Base Editing Pipeline for Inborn Errors of Immunity: Proof-of-Concept in ADA-SCID Q3X
CIHR · 2025 · Supervisor
$140,000
RAre Disease Administrative Data Research (RADAR) Team: putting the health system impact of rare diseases on the radar
CIHR · 2023 · Co-investigator
$1,598,238
A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.
CIHR · 2022 · Nominated PI
$606,576

All 4 grants and awards

14 publications.

Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.

Doucette EJ, Ricketson LJ, Murguía-Favela L, Wright N, Kellner JD

Vaccine2026

DOI: 10.1016/j.vaccine.2026.128977 PMID: 42561781

Hospitalization Through Families' Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada.

Zwicker HM, Kemp K, Tutelman P, Hou SHJ, Fairie P, Santana M, Guilcher GMT, Fay-McClymont T, Bendiak G, Pelletier W, Wright N, Schulte F

Pediatric blood & cancer2026

DOI: 10.1002/1545-5017.70386 PMID: 42135994

Reducing antibiotic overuse in immunocompetent children with febrile neutropenia in a pediatric emergency department: a quality improvement initiative.

Girgulis K, Thull-Freedman J, Wright N

CJEM2026Senior author

DOI: 10.1007/s43678-026-01091-9 PMID: 41632376

Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study.

Brumm VL, Kidd SA, Logan BR, Chunara F, Heimall J, Griffith LM, Kohn DB, Sanchez L, Bednarski JJ, Martinez C, Lugt MV, Kapoor N, Wright N, Spitzer B, Oved JH, Chandra S, Chellapandian D, Ebens CL, Petrovic A, Rayes A, Haines HL, Lust H, Schofield HT, Christopher L, Harris LL, Satter LF, Burroughs L, Dvorak CC, Haddad E, Leiding JW, Marsh RA, Notarangelo LD, Pai SY, Pulsipher MA, Puck JM, Cowan MJ, Shah AJ

Journal of human immunity2026

DOI: 10.70962/jhi.20250163 PMID: 41608119

Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.

Chandrasekaran P, Han Y, Zerbe CS, Heller T, DeRavin SS, Kreuzberg SA, Marciano BE, Siu Y, Jones DR, Abraham RS, Stephens MC, Tsou AM, Snapper S, Conlan S, Subramanian P, Quinones M, Grou C, Calderon V, Deming C, Leiding JW, Arnold DE, Logan BR, Griffith LM, Petrovic A, Mousallem TI, Kapoor N, Heimall JR, Barnum JL, Kapadia M, Wright N, Rayes A, Chandra S, Broglie LA, Chellapandian D, Deal CL, Grunebaum E, Lim SS, Mallhi K, Marsh RA, Murguia-Favela L, Parikh S, Touzot F, Cowan MJ, Dvorak CC, Haddad E, Kohn DB, Notarangelo LD, Pai SY, Puck JM, Pulsipher MA, Torgerson TR, Kang EM, Malech HL, Segre JA, Bryant CE, Holland SM, Falcone EL

The Journal of allergy and clinical immunology2023

DOI: 10.1016/j.jaci.2023.07.022 PMID: 37659505

Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing.

McAuley GE, Yiu G, Chang PC, Newby GA, Campo-Fernandez B, Fitz-Gibbon ST, Wu X, Kang SL, Garibay A, Butler J, Christian V, Wong RL, Everette KA, Azzun A, Gelfer H, Seet CS, Narendran A, Murguia-Favela L, Romero Z, Wright N, Liu DR, Crooks GM, Kohn DB

Cell2023

DOI: 10.1016/j.cell.2023.02.027 PMID: 36944331

The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing.

Zhou JR, Ridsdale R, MacNeil L, Lilley M, Hoang S, Christian S, Blumenschein P, Wolan V, Bruce A, Singh G, Wright N, Parboosingh JS, Lamont RE, Sosova I

International journal of neonatal screening2021

DOI: 10.3390/ijns7040078 PMID: 34842602

Correction to: 2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference.

Kalashnikova T, Wright N, Midgley J, Bernier F, Luider J, Murguia-Favela L

Journal of clinical immunology2020

DOI: 10.1007/s10875-020-00818-2 PMID: 32653965

Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices.

Knight V, Heimall JR, Wright N, Dutmer CM, Boyce TG, Torgerson TR, Abraham RS

International journal of neonatal screening2020

DOI: 10.3390/ijns6030052 PMID: 33239578

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.

Chan AY, Leiding JW, Liu X, Logan BR, Burroughs LM, Allenspach EJ, Skoda-Smith S, Uzel G, Notarangelo LD, Slatter M, Gennery AR, Smith AR, Pai SY, Jordan MB, Marsh RA, Cowan MJ, Dvorak CC, Craddock JA, Prockop SE, Chandrakasan S, Kapoor N, Buckley RH, Parikh S, Chellapandian D, Oshrine BR, Bednarski JJ, Cooper MA, Shenoy S, Davila Saldana BJ, Forbes LR, Martinez C, Haddad E, Shyr DC, Chen K, Sullivan KE, Heimall J, Wright N, Bhatia M, Cuvelier GDE, Goldman FD, Meyts I, Miller HK, Seidel MG, Vander Lugt MT, Bacchetta R, Weinacht KG, Andolina JR, Caywood E, Chong H, de la Morena MT, Aquino VM, Shereck E, Walter JE, Dorsey MJ, Seroogy CM, Griffith LM, Kohn DB, Puck JM, Pulsipher MA, Torgerson TR

Frontiers in immunology2020

DOI: 10.3389/fimmu.2020.00239 PMID: 32153572

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2022

Subject: Prospective PhD student: Adenine Base Editing Dear Professor Wright, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024." (2026), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency." (2022), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Nicola Wright

Research

Latest papers

Latest funding

Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.

Hospitalization Through Families' Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada.

Reducing antibiotic overuse in immunocompetent children with febrile neutropenia in a pediatric emergency department: a quality improvement initiative.

Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study.

Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.

Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing.

The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing.

Correction to: 2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference.

Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices.

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.

Building the First Made-in-Canada Base Editing Pipeline for Inborn Errors of Immunity: Proof-of-Concept in ADA-SCID Q3X

RAre Disease Administrative Data Research (RADAR) Team: putting the health system impact of rare diseases on the radar

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

Frequent collaborators

Luis Murguia-Favela

Elie Haddad

Aru Narendran

Perri Tutelman

Francois Bernier

Kyle Kemp

Mary Brindle

Fiona Schulte

Paul Fairie

Fabien Touzot

Nicola Wright

Research

Latest papers

Latest funding

Clinical features and outcomes of pediatric breakthrough invasive pneumococcal disease (IPD) in vaccinated children in Calgary, Alberta, Canada, 2003-2024.

Hospitalization Through Families' Eyes: Comparing Inpatient Care Quality for Children With Sickle Cell Disease and Cystic Fibrosis in Canada.

Reducing antibiotic overuse in immunocompetent children with febrile neutropenia in a pediatric emergency department: a quality improvement initiative.

Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study.

Intestinal microbiome and metabolome signatures in patients with chronic granulomatous disease.

Human T&#xa0;cell generation is restored in CD3&#x3b4; severe combined immunodeficiency through adenine base editing.

The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing.

Correction to: 2020 CIS Annual Meeting: Immune Deficiency & Dysregulation North American Conference.

Follow-Up for an Abnormal Newborn Screen for Severe Combined Immunodeficiencies (NBS SCID): A Clinical Immunology Society (CIS) Survey of Current Practices.

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey.

Building the First Made-in-Canada Base Editing Pipeline for Inborn Errors of Immunity: Proof-of-Concept in ADA-SCID Q3X

RAre Disease Administrative Data Research (RADAR) Team: putting the health system impact of rare diseases on the radar

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

A pilot project to demonstrate feasibility of a Canadian gene therapy clinical trials platform for rare genetic diseases: Gene Therapy for CD3delta Severe Combined Immune Deficiency.

Frequent collaborators

Luis Murguia-Favela

Elie Haddad

Aru Narendran

Perri Tutelman

Francois Bernier

Kyle Kemp

Mary Brindle

Fiona Schulte

Paul Fairie

Fabien Touzot

Human T cell generation is restored in CD3δ severe combined immunodeficiency through adenine base editing.